Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
November 2, 2018

Cancer Center among best in nation for stem cell transplant survival

Vanderbilt-Ingram Cancer Stem Cell Transplant ranks among the best in the nation for donor stem cell transplant survival rates among large centers, according to an annual report.

By Tom Wilemon
November 1, 2018

Cancer epigenetics expert Baylin set for Discovery Lecture

Stephen Baylin, MD, a trailblazer in the study of the epigenetics of cancer, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 8. His lecture, sponsored by the Vanderbilt-Ingram Cancer Center, will begin at 4 p.m. in room 208 Light Hall.

By Bill Snyder
November 1, 2018

Warner’s medical informatics research recognized

Jeremy Warner, MD, is the 2018 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).

By Tom Wilemon
October 25, 2018

Combination therapy improves small-cell lung cancer survival

Patients with stage IV small-cell lung cancer lived longer when given the immunotherapy atezolizumab with chemotherapy, setting the stage for what could become the first new treatment approved in decades for this particularly aggressive form of lung cancer.

By Tom Wilemon
October 18, 2018

Bart Magowan is a man on the road, working in four clinics spanning three counties an hour apart

“I have a great team around me. The staff and physicians that work at these individual clinics and also my leaders make it a pleasure.”

By Leigh MacMillan
October 18, 2018

Grant enhances study of new chemotherapy targets

Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

By Tom Wilemon
October 11, 2018

Cancer Center investigators awarded Komen grants

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
October 4, 2018

VICC’s Levy to lead Rush University Cancer Center

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.
By Tom Wilemon
October 4, 2018

Cochran celebrates cancer treatment’s end in style

Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father.
By Tom Wilemon
September 27, 2018

Team’s potential lung cancer therapy lands award from SBIR

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.
By Tom Wilemon
September 20, 2018

Chic Awearness event supports VUMC ovarian cancer research

The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.
By Tom Wilemon
September 13, 2018

Study tracks incidence, timing of immunotherapy-related deaths

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.
By Tom Wilemon
September 13, 2018

Honoring Byrd

Members of the Byrd family gathered at Vanderbilt-Ingram Cancer Center recently to dedicate a portrait of the late Benjamin F. Byrd Jr., MD, a founding member and first chair of the Cancer Center’s Board of Overseers.
By VUMC News and Communications
1 … 21 22 23 24 25 … 55